United States set
language
Menu Shopping cart $0 Search
Manufactured by BioVendor

Phosphorylated Neurofilament H Human ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA, HRP-labelled antibody
  • Other names:pNF-H
  • Species:Human
Cat. No. Size Price


RD191138300R 96 wells (1 kit) $629
PubMed Product Details
Technical Data

Type

Sandwich ELISA, HRP-labelled antibody

Applications

Serum, Cerebrospinal fluid, Tissue extract, Plasma

Shipping

At ambient temperature. Upon receipt, store the product at the temperature recommended below.

Storage/Expiration

Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

62.5–4000 pg/ml

Limit of Detection

23.5 pg/ml

Intra-assay (Within-Run)

n = 8; CV = 4.5%

Spiking Recovery

CSF sample: 98.8%
Serum sample: 95.8%

Dilution Linearity

CSF sample: 106.1%
Serum sample: 105.5%

Summary

Features

  • It is intended for research use only.
  • The total assay time is less than 4 hours.
  • The kit measures pNF-H in serum, plasma, cerebrospinal fluid (CSF) and tissue samples
  • Assay format is 96 wells.
  • Standard and Quality Controls are human brain extract based. No animal sera are used.
  • Components of the kit are provided ready to use, concentrated or lyophilized.

Research topic

Neural tissue markers, Oncology

Summary

Neurofilaments are the 10nm diameter filaments which are the most abundant protein components of neurons and are particularly concentrated in axons. They belong to the intermediate or 10nm filament protein/gene superfamily which also includes keratins, the major structural proteins of skin. Neurofilaments (NF) consist predominantly of three subunits:, NF-L (low), NF-M (medium), and NF-H (heavy or high). NF-H protein is about 200 kDa and contains unusual multiple repeated sequence lysine-serine-proline (KSP), and in axonal neurofilaments essentially all serine residues are heavily phosphorylated. Because phosphorylated forms of NFH (pNF-H) are quite resistant to proteases, pNF-H released from damaged and diseased axons should remain in fluid undegraded. This means that detection of pNF-H in blood and CSF points unambiguously to neuronal damage due to the fact that pNF-H is found exclusively in neurons.
This protein can be detected in quite large amounts following experimental spinal cord and brain injury in rats. Levels of greater than 100 ng/ml of pNF-H were detectable in blood following serious cord injury and lower, but still easily detectable levels, were found in blood of animals given experimental brain injury. In recently studies with rats subjected to traumatic brain injury (TBI) using a controlled cortical impact (CCI) device, elevated blood pNF-H levels were found. Results show time-dependent changes in the detectable pNF-H levels and these levels correspond with the severity of the injury and the amount of cortical damage.
Studies with mice transgenic for mutations of human copper/zinc superoxide dismutase 1 which are associated with amyotrophic lateral sclerosis (ALS) have revealed corresponding increased amounts of pNF-H in blood of these animals. These mice develop axonal degeneration pathology similar to that seen in humans with ALS, and blood pNF-H levels can be used to monitor this degeneration. Interestingly, pNF-H is detectable before the onset of obvious disease symptoms.
Other experiments have shown that pNF-H is detected in the plasma of humans suffering from optic neuritis and in elevated levels in the cerebrospinal fluid (CSF) of individuals suffering from brain tumors and stroke.

Product References (32)

References

  • Falzone YM, Domi T, Agosta F, Pozzi L, Schito P, Fazio R, Del Carro U, Barbieri A, Comola M, Leocani L, Comi G, Carrera P, Filippi M, Quattrini A, Riva N. Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease. J Neurol. 2020 Aug;267(8):2272-2280. doi: 10.1007/s00415-020-09838-9. Epub 2020 Apr 18. PubMed PMID: 32306171. PubMed CentralPMCID: PMC7166001. See more on PubMed
  • Costa J, Pronto-Laborinho A, Pinto S, Gromicho M, Bonucci S, Tranfield E, Correia C, Alexandre BM, de Carvalho M. Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases. Sci Rep. 2020 Mar 27;10(1):5649. doi: 10.1038/s41598-020-62592-w. PubMed PMID: 32221402. PubMed CentralPMCID: PMC7101329. See more on PubMed
  • Li YP, Yan ZQ, Han LP, Yin AL, Xu JY, Zhai YR, Hao S, Zhang L, Xie Y. The Association Between Phosphorylated Neurofilament Heavy Chain (pNF-H) and Small Fiber Neuropathy (SFN) in Patients with Impaired Glucose Tolerance. Diabetes Ther. 2020 Jan;11(1):71-81. doi: 10.1007/s13300-019-00716-w. Epub 2019 Oct 30. PubMed PMID: 31673971. PubMed CentralPMCID: PMC6965567. See more on PubMed
  • Yokobori S, Wang KKK, Yang Z, Zhu T, Tyndall JA, Mondello S, Shibata Y, Tominaga N, Kanaya T, Takiguchi T, Igarashi Y, Hagiwara J, Nakae R, Onda H, Masuno T, Fuse A, Yokota H. Quantitative pupillometry and neuron-specific enolase independently predict return of spontaneous circulation following cardiogenic out-of-hospital cardiac arrest: a prospective pilot study. Sci Rep. 2018 Oct 29;8(1):15964. doi: 10.1038/s41598-018-34367-x. PubMed PMID: 30374189. PubMed CentralPMCID: PMC6206016. See more on PubMed
  • Sacktor N, Skolasky RL, Moxley R, Wang S, Mielke MM, Munro C, Steiner J, Nath A, Haughey N, McArthur J. Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial. J Neurovirol. 2018 Feb;24(1):16-27. doi: 10.1007/s13365-017-0587-z. Epub 2017 Oct 23. PubMed PMID: 29063516. PubMed CentralPMCID: PMC5792316. See more on PubMed
  • Wurster CD, Günther R, Steinacker P, Dreyhaupt J, Wollinsky K, Uzelac Z, Witzel S, Kocak T, Winter B, Koch JC, Lingor P, Petri S, Ludolph AC, Hermann A, Otto M. Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment. Ther Adv Neurol Disord. 2019 May 10;12:1756286419846058. doi: 10.1177/1756286419846058. eCollection 2019. PubMed PMID: 31205491. PubMed CentralPMCID: PMC6535708. See more on PubMed
  • Kuwajima K, Sumitani M, Kurano M, Kano K, Nishikawa M, Uranbileg B, Tsuchida R, Ogata T, Aoki J, Yatomi Y, Yamada Y. Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study. PLoS One. 2018 Nov 8;13(11):e0207310. doi: 10.1371/journal.pone.0207310. eCollection 2018. PubMed PMID: 30408112. PubMed CentralPMCID: PMC6224112. See more on PubMed
  • Sandsmark DK, Bogoslovsky T, Qu BX, Haber M, Cota MR, Davis C, Butman JA, Latour LL, Diaz-Arrastia R. Changes in Plasma von Willebrand Factor and Cellular Fibronectin in MRI-Defined Traumatic Microvascular Injury. Front Neurol. 2019 Mar 26;10:246. doi: 10.3389/fneur.2019.00246. eCollection 2019. PubMed PMID: 30972003. PubMed CentralPMCID: PMC6445052. See more on PubMed
  • Pawliszak W, Szwed K, Słomka A, Piekuś-Słomka N, Szwed M, Kowalewski M, Żekanowska E, Borkowska A. Three-vessel coronary artery disease may predict changes in biochemical brain injury markers after off-pump coronary artery bypass grafting(). J Zhejiang Univ Sci B. 2018 Sept.;19(9):735-738. doi: 10.1631/jzus.B1700553. PubMed PMID: 30178640. PubMed CentralPMCID: PMC6137419. See more on PubMed
  • Yang Z, Bramlett HM, Moghieb A, Yu D, Wang P, Lin F, Bauer C, Selig TM, Jaalouk E, Weissman AS, Rathore DS, Romo P, Zhang Z, Hayes RL, Wang MY, Dietrich WD, Wang KKW. Temporal Profile and Severity Correlation of a Panel of Rat Spinal Cord Injury Protein Biomarkers. Mol Neurobiol. 2018 Mar;55(3):2174-2184. doi: 10.1007/s12035-017-0424-7. Epub 2017 Mar 13. PubMed PMID: 28290147. See more on PubMed
  • Denk J, Oberhauser F, Kornhuber J, Wiltfang J, Fassbender K, Schroeter ML, Volk AE, Diehl-Schmid J, Prudlo J, Danek A, Landwehrmeyer B, Lauer M, Otto M, Jahn H. Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls. PLoS One. 2018 May 10;13(5):e0197329. doi: 10.1371/journal.pone.0197329. eCollection 2018. PubMed PMID: 29746584. PubMed CentralPMCID: PMC5945001. See more on PubMed
  • Inoue R, Sumitani M, Ogata T, Chikuda H, Matsubara T, Kato S, Shimojo N, Uchida K, Yamada Y. Direct evidence of central nervous system axonal damage in patients with postoperative delirium: A preliminary study of pNF-H as a promising serum biomarker. Neurosci Lett. 2017 Jul 13;653:39-44. doi: 10.1016/j.neulet.2017.05.023. Epub 2017 May 11. PubMed PMID: 28504118. See more on PubMed
  • Lehmer C, Oeckl P, Weishaupt JH, Volk AE, Diehl-Schmid J, Schroeter ML, Lauer M, Kornhuber J, Levin J, Fassbender K, Landwehrmeyer B, Schludi MH, Arzberger T, Kremmer E, Flatley A, Feederle R, Steinacker P, Weydt P, Ludolph AC, Edbauer D, Otto M. Poly-GP in cerebrospinal fluid links C9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD. EMBO Mol Med. 2017 Jul;9(7):859-868. doi: 10.15252/emmm.201607486. PubMed PMID: 28408402. PubMed CentralPMCID: PMC5494528. See more on PubMed
  • Singh A, Kumar V, Ali S, Mahdi AA, Srivastava RN. Phosphorylated neurofilament heavy: A potential blood biomarker to evaluate the severity of acute spinal cord injuries in adults. Int J Crit Illn Inj Sci. 2017 Oct-Dec;7(4):212-217. doi: 10.4103/IJCIIS.IJCIIS_73_16. PubMed PMID: 29291173. PubMed CentralPMCID: PMC5737062. See more on PubMed
  • Pironkova RP, Giamelli J, Seiden H, Parnell VA, Gruber D, Sison CP, Kowal C, Ojamaa K. Brain injury with systemic inflammation in newborns with congenital heart disease undergoing heart surgery. Exp Ther Med. 2017 Jul;14(1):228-238. doi: 10.3892/etm.2017.4493. Epub 2017 May 22. PubMed PMID: 28672919. PubMed CentralPMCID: PMC5488503. See more on PubMed
  • Li S, Ren Y, Zhu W, Yang F, Zhang X, Huang X. Phosphorylated neurofilament heavy chain levels in paired plasma and CSF of amyotrophic lateral sclerosis. J Neurol Sci. 2016 Aug 15;367:269-74. doi: 10.1016/j.jns.2016.05.062. Epub 2016 Jun 1. PubMed PMID: 27423602. See more on PubMed
  • Chen X, Chen Y, Wei Q, Ou R, Cao B, Zhao B, Shang HF. Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis. BMC Neurol. 2016 Sep 15;16:173. doi: 10.1186/s12883-016-0689-x. PubMed PMID: 27634542. PubMed CentralPMCID: PMC5024522. See more on PubMed
  • Sumitani M, Ogata T, Natori A, Hozumi J, Shimojo N, Kida K, Yamauchi H, Yamauchi T. Poor efficacy of the phosphorylated high-molecular-weight neurofilament heavy subunit serum level, a biomarker of axonal damage, as a marker of chemotherapy-induced peripheral neuropathy. Biomed Rep. 2016 Jun;4(6):758-760. doi: 10.3892/br.2016.648. Epub 2016 Apr 8. PubMed PMID: 27284419. PubMed CentralPMCID: PMC4887842. See more on PubMed
  • McGuire JL, Gill AJ, Douglas SD, Kolson DL. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders. J Neurovirol. 2015 Aug;21(4):439-48. doi: 10.1007/s13365-015-0333-3. Epub 2015 Mar 17. PubMed PMID: 25776526. PubMed CentralPMCID: PMC4511078. See more on PubMed
  • Steinacker P, Feneberg E, Weishaupt J, Brettschneider J, Tumani H, Andersen PM, von Arnim CA, Böhm S, Kassubek J, Kubisch C, Lulé D, Müller HP, Muche R, Pinkhardt E, Oeckl P, Rosenbohm A, Anderl-Straub S, Volk AE, Weydt P, Ludolph AC, Otto M. Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients. J Neurol Neurosurg Psychiatry. 2016 Jan;87(1):12-20. doi: 10.1136/jnnp-2015-311387. Epub 2015 Aug 21. PubMed PMID: 26296871. See more on PubMed
  • Qiao X, Zhang S, Zhao W, Ye H, Yang Y, Zhang Z, Miao Q, Hu R, Li Y, Lu B. Serum Phosphorylated Neurofilament-Heavy Chain, a Potential Biomarker, is Associated With Peripheral Neuropathy in Patients With Type 2 Diabetes. Medicine (Baltimore). 2015 Nov;94(44):e1908. doi: 10.1097/MD.0000000000001908. PubMed PMID: 26554790. PubMed CentralPMCID: PMC4915891. See more on PubMed
  • Natori A, Ogata T, Sumitani M, Kogure T, Yamauchi T, Yamauchi H. Potential role of pNF-H, a biomarker of axonal damage in the central nervous system, as a predictive marker of chemotherapy-induced cognitive impairment. Clin Cancer Res. 2015 Mar 15;21(6):1348-52. doi: 10.1158/1078-0432.CCR-14-2775. Epub 2015 Jan 14. PubMed PMID: 25589615. See more on PubMed
  • Takahashi H, Aoki Y, Nakajima A, Sonobe M, Terajima F, Saito M, Taniguchi S, Yamada M, Watanabe F, Furuya T, Koda M, Yamazaki M, Takahashi K, Nakagawa K. Phosphorylated neurofilament subunit NF-H becomes elevated in the cerebrospinal fluid of patients with acutely worsening symptoms of compression myelopathy. J Clin Neurosci. 2014 Dec;21(12):2175-8. doi: 10.1016/j.jocn.2014.04.021. Epub 2014 Jul 22. PubMed PMID: 25065845. See more on PubMed
  • Gonçalves M, Tillack L, de Carvalho M, Pinto S, Conradt HS, Costa J. Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis. Clin Chim Acta. 2015 Jan 1;438:342-9. doi: 10.1016/j.cca.2014.09.011. Epub 2014 Sep 28. PubMed PMID: 25261856. See more on PubMed
  • Cai JY, Lu C, Chen MH, Ba HJ, Chen XD, Lin JH, Sun J. Predictive value of phosphorylated axonal neurofilament subunit H for clinical outcome in patients with acute intracerebral hemorrhage. Clin Chim Acta. 2013 Sep 23;424:182-6. doi: 10.1016/j.cca.2013.06.019. Epub 2013 Jun 26. PubMed PMID: 23810564. See more on PubMed
  • Pranzatelli MR, Tate ED, McGee NR, Verhulst SJ. CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders. J Neuroimmunol. 2014 Jan 15;266(1-2):75-81. doi: 10.1016/j.jneuroim.2013.11.004. Epub 2013 Nov 16. PubMed PMID: 24342231. See more on PubMed
  • Fialová L, Bartos A, Švarcová J, Zimova D, Kotoucova J. Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis. J Neuroimmunol. 2013 Jun 15;259(1-2):81-7. doi: 10.1016/j.jneuroim.2013.03.009. Epub 2013 Apr 28. PubMed PMID: 23632043. See more on PubMed
  • Vajtr D, Benada O, Linzer P, Sámal F, Springer D, Strejc P, Beran M, Průša R, Zima T. Immunohistochemistry and serum values of S-100B, glial fibrillary acidic protein, and hyperphosphorylated neurofilaments in brain injuries. Soud Lek. 2012 Jan;57(1):7-12. PubMed PMID: 22724589. See more on PubMed
  • Žurek J, Fedora M. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochir (Wien). 2012 Jan;154(1):93-103; discussion 103. doi: 10.1007/s00701-011-1175-2. PubMed PMID: 21976236. See more on PubMed
  • Gresle MM, Butzkueven H, Shaw G. Neurofilament proteins as body fluid biomarkers of neurodegeneration in multiple sclerosis. Mult Scler Int. 2011;2011:315406. doi: 10.1155/2011/315406. Epub 2011 Jan 23. PubMed PMID: 22096635. PubMed CentralPMCID: PMC3195785. See more on PubMed
  • Ganesalingam J, An J, Shaw CE, Shaw G, Lacomis D, Bowser R. Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. J Neurochem. 2011 May;117(3):528-37. doi: 10.1111/j.1471-4159.2011.07224.x. Epub 2011 Mar 21. PubMed PMID: 21418221. PubMed CentralPMCID: PMC3076545. See more on PubMed
  • Zurek J, Bartlová L, Fedora M. Hyperphosphorylated neurofilament NF-H as a predictor of mortality after brain injury in children. Brain Inj. 2011;25(2):221-6. doi: 10.3109/02699052.2010.541895. PubMed PMID: 21219092. See more on PubMed
Summary References (7)

References to Phosphorylated Neurofilament H

  • Anderson KJ, Scheff SW, Miller KM, Roberts KN, Gilmer LK, Yang C, Shaw G. The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury. J Neurotrauma. 2008 Sep;25 (9):1079-85
  • Hu YY, He SS, Wang XC, Duan QH, Khatoon S, Iqbal K, Grundke-Iqbal I, Wang JZ. Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients. Neurosci Lett. 2002 Mar 8;320 (3):156-60
  • Lewis SB, Wolper RA, Miralia L, Yang C, Shaw G. Detection of phosphorylated NF-H in the cerebrospinal fluid and blood of aneurysmal subarachnoid hemorrhage patients. J Cereb Blood Flow Metab. 2008 Jun;28 (6):1261-71
  • Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci. 2005 Jun 15;233 (1-2):183-98
  • Petzold A, Rejdak K, Plant GT. Axonal degeneration and inflammation in acute optic neuritis. J Neurol Neurosurg Psychiatry. 2004 Aug;75 (8):1178-80
  • Petzold A, Shaw G. Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain. J Immunol Methods. 2007 Jan 30;319 (1-2):34-40
  • Shaw G, Yang C, Ellis R, Anderson K, Parker Mickle J, Scheff S, Pike B, Anderson DK, Howland DR. Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury. Biochem Biophys Res Commun. 2005 Nov 4;336 (4):1268-77
Related Products Docs